EAT is up +49.38%% since April’24 pick View All Top Buy Picks
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARTH
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Arch Therapeutics Inc
(Updated on Jun 28, 2024)

Hold candidate since Jun 26, 2024 PDF

No changes to the price of Arch Therapeutics Inc stock on the last trading day (Friday, 28th Jun 2024). During the last trading day the stock fluctuated 0% from a day low at $0.86 to a day high of $0.86. The price has been going up and down for this period, and there has been a -14% loss for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -34.43% during the next 3 months and, with a 90% probability hold a price between $0.345 and $0.81 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARTH Signals & Forecast

There are mixed signals in the stock today. The Arch Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.89 and $1.06. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, June 24, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation

Support, Risk & Stop-loss for Arch Therapeutics Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.81 (-6.32%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 24 days ago.)

Trading Expectations (ARTH) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Arch Therapeutics Inc to open at $0.86, and during the day (based on 14 day Average True Range), to move between $0.80 and $0.92, which gives a possible trading interval of +/-$0.0556 (+/-6.46%) up or down from last closing price. If Arch Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 12.92% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.93, some $0.0650 (7.56%) from the current price of $0.86, our system finds the risk reward not very attractive.

Is Arch Therapeutics Inc stock A Buy?

Arch Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Arch Therapeutics Inc of Monday, July 1, 2024

Fair opening price July 1, 2024 Current price
$0.86 ( 0%) $0.86

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARTH

Fibonacci Support & Resistance Levels

Level Price
R3 0.86 -
R2 0.86 -
R1 0.86 -
Price 0.86
S1 0.86 -
S2 0.86 -
S3 0.86 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.05 22.09%
R2 0.95 10.47%
R1 0.93 7.56%
Price 0.86
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Arch Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Arch Therapeutics Inc is ARTH and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Arch Therapeutics Inc Stock?
Arch Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Arch Therapeutics Inc Stock?
Arch Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arch Therapeutics Inc Stock.

What's the current price of Arch Therapeutics Inc Stock?
As of the end of day on the Jun 28, 2024, the price of an Arch Therapeutics Inc (ARTH) share was $0.86.

What is the 52-week high and low for Arch Therapeutics Inc Stock?
The 52-week high for Arch Therapeutics Inc Stock is $18.00 and the 52-week low is $0.390.

What is the market capitalization of Arch Therapeutics Inc Stock?
As of the Jun 28, 2024, the market capitalization of Arch Therapeutics Inc is 477.783K.

When is the next earnings date for Arch Therapeutics Inc?
The upcoming earnings date for Arch Therapeutics Inc is Aug 09, 2024.
Click to get the best stock tips daily for free!

About Arch Therapeutics Inc

Arch Therapeutics Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin a... ARTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT